PDS Biotech principal accounting officer Janetta Trochimiuk files initial beneficial ownership statement

PDS Biotechnology Principal Accounting Officer Janetta Trochimiuk reported 1,124 common shares in an initial SEC Form 3 filing. Filing also disclosed stock options covering 228,867 shares with exercise prices from $0.98 to $11.61. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PDS Biotechnology Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-037142), on September 18, 2026, and is solely responsible for the information contained therein. (C)